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Abstract: Background and aims: Cross-sectional twin and family studies 
report a moderate heritability of baseline levels of C-reactive protein 
(CRP) ranging from 0.10 to 0.65 for different age ranges. Here, we 
investigated the stability and relative impact of genetic and 
environmental factors underlying serum levels of CRP, using a 
longitudinal classical twin design. 
Methods: A maximum of 6,201 female twins from the TwinsUK registry with 
up to three CRP measurements (i.e. visit 1 [V1], visit 2 [V2] and visit 3 
[V3]) over a 10 year follow-up period were included in this study. 
Structural equation modeling was applied to dissect the observed 
phenotypic variance into its genetic and environ-mental components. To 
estimate the heritability of CRP as well as its genetic and environmental 
correlations across different time points, a trivariate model was used.  
Results: Natural log (ln) CRP levels significantly increased from V1 to 
V2 (p=4.4x10-25) and between V1 and V3 (p=1.2x10-15), but not between V2 
and V3. The median (IQR) follow-up time between V1 and V3 was 9.58 (8.00-
10.46) years. Heritability estimates for CRP were around 50% and constant 
over time (0.46-0.52). Additionally adjustment for BMI did not meaningful 
change the heritability estimates (0.49-0.51). The genetic correlations 
between visits were significantly smaller than one, ranging from 0.66 to 
0.85.  
Conclusions: The present study provides evidence for stable heritability 
estimates of CRP of around 50% with advancing age. However, between-visit 
genetic correlations are significantly lower than 1 indicating emergence 
of new genetic effects on CRP levels with age. 
 
 
 
 
 
Highlights 
 
 Heritability estimates of C-reactive Protein (CRP) are around 50% and remain 
stable with advancing age. 
 Adjustment for body mass index did not change heritability estimates of CRP.  
 New genetic effects on CRP levels emerge with advancing age. 
Highlights
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Abstract 42 
Background and aims: Cross-sectional twin and family studies report a moderate 43 
heritability of baseline levels of C-reactive protein (CRP) ranging from 0.10 to 0.65 for 44 
different age ranges. Here, we investigated the stability and relative impact of genetic 45 
and environmental factors underlying serum levels of CRP, using a longitudinal 46 
classical twin design. 47 
Methods: A maximum of 6,201 female twins from the TwinsUK registry with up to 48 
three CRP measurements (i.e. visit 1 [V1], visit 2 [V2] and visit 3 [V3]) over a 10 year 49 
follow-up period were included in this study. Structural equation modeling was 50 
applied to dissect the observed phenotypic variance into its genetic and environ-51 
mental components. To estimate the heritability of CRP as well as its genetic and 52 
environmental correlations across different time points, a trivariate model was used.  53 
Results: Natural log (ln) CRP levels significantly increased from V1 to V2 (p=4.4x10-54 
25) and between V1 and V3 (p=1.2x10-15), but not between V2 and V3. The median 55 
(IQR) follow-up time between V1 and V3 was 9.58 (8.00-10.46) years. Heritability 56 
estimates for CRP were around 50% and constant over time (0.46-0.52). Additionally 57 
adjustment for BMI did not meaningful change the heritability estimates (0.49–0.51). 58 
The genetic correlations between visits were significantly smaller than one, ranging 59 
from 0.66 to 0.85.  60 
Conclusions: The present study provides evidence for stable heritability estimates of 61 
CRP of around 50% with advancing age. However, between-visit genetic correlations 62 
are significantly lower than 1 indicating emergence of new genetic effects on CRP 63 
levels with age. 64 
 65 
Keywords: aging, longitudinal, twins, heritability, C-reactive protein 66 
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Introduction 67 
The link between ageing and inflammation is well established. Low levels of microbial 68 
exposition early in life is known to promote the development of more competent 69 
immune pathways and regulatory processes. Such effective anti-inflammatory 70 
networks may counterbalance proinflammatory pathways (and CRP levels) activated 71 
by chronic diseases such as obesity and atherosclerosis [1]. Furthermore, ageing is 72 
known to be associated with a gradual dysregulation of inflammatory pathways 73 
resulting in an elevation of inflammatory factors [2–5]. It has been demonstrated that 74 
chronic low grade inflammation predisposes to many chronic, age-related diseases, 75 
such as those of the pulmonary and cardiovascular system [6–9]. We have 76 
previously demonstrated the role of age as a moderator of the genetic and 77 
environmental influences on baseline levels of inflammatory markers.[10]. 78 
An important, well established inflammatory marker is C-reactive protein 79 
(CRP). Its baseline levels are considered to reflect systemic inflammation. 80 
Considering the relationship of increased baseline CRP levels with a variety of 81 
disorders, including cancer [11], bipolar disorder [12], cardiovascular diseases [13–82 
15], type 2 diabetes [16], and all-cause mortality [17], regulation of baseline CRP 83 
levels are of particular interest. In this context, baseline CRP levels have shown to be 84 
influenced by a variety of environmental and genetic factors. However, their relative 85 
importance and exact extent to which these factors account for the total variance in 86 
CRP level remains unknown [18].  87 
Heritability studies aim to estimate the relative influence of heritable and 88 
environmental factors on a trait [19]. Twin and family studies in a wide variety of 89 
populations with different age ranges showed a moderate heritability of baseline CRP 90 
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levels, with heritability estimates ranging from 0.10 to 0.65 [20–40] (Supplementary 91 
Table 3).  92 
CRP levels have been shown to be fairly stable over time. DeGoma et al. [41] 93 
analyzed serial CRP measures of 255 participants to evaluate the intraindividual 94 
variability of CRP over a median follow up period of 4.7 years. The multivariable-95 
adjusted intraclass correlation coefficient (ICC) of CRP was estimated as 0.62. The 96 
intraindividual variability of CRP was also investigated by Wu et al. [42], using CRP 97 
levels of 56,218 Chinese adults over a two-year follow-up time. The ICC of CRP was 98 
reported as 0.55 for men and 0.60 for women. Interestingly, the stability of CRP 99 
gradually increased with age. However, twin and family studies mentioned above 100 
used single CRP measurement for their heritability calculation rather than longitudinal 101 
measurements. Limited by this cross-sectional design, heritability estimates for CRP 102 
as reported above only provide a snapshot at one particular point in time, potentially 103 
providing at least a partial explanation for the wide variety of heritability estimates 104 
reported in the literature [20–40]. 105 
To the best of our knowledge, no longitudinal twin studies on CRP levels have 106 
been conducted to date. The aim of this study was to evaluate the heritabilities and 107 
the extent to which genetic and environmental influences contribute to the stability or 108 
change of CRP over time in a large population of adult females using a classical twin 109 
design, including up to three CRP measurements over a ten year follow-up period. 110 
 111 
Material and Methods 112 
Subjects 113 
The study was conducted in 6,201 women from the Twins UK registry. Details of the 114 
Twins UK registry have been published before [43]. Zygosity was determined by 115 
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questionnaire supplemented by DNA fingerprinting in cases with disputed or 116 
uncertain zygosity. CRP measurement follow-up was performed up to 3 times, giving 117 
6,201 measurements in visit 1 (1,457 monozygotic (MZ) pairs, 1,584 dizygotic (DZ) 118 
pairs and 119 singletons), 2,251 measurements in visit 2 (452 MZ-pairs, 632 DZ-119 
pairs and 83 singletons) and 528 measurements in visit 3 (139 MZ-pairs, 112 DZ-120 
pairs and 26 singletons). 121 
 122 
C-reactive protein analysis 123 
High sensitive CRP was measured by latex-enhanced nephelometry on a Siemens 124 
(formally Behring) Prospec Nephelometer. The intra-assay precision expressed as 125 
coefficient of variation (CV) of this method is around 3.5% CV at 1.5 mg/l and 3.1% at 126 
12 mg/l and is expected to be <2% CV across the linear range of the assay. 127 
 128 
Analytical approach  129 
Natural log (ln) transformation was necessary for the CRP data in order to obtain a 130 
better approximation of the normal distribution. Secondly, lnCRP was adjusted for 131 
age. This is a common procedure in twin analyses because age can spuriously 132 
introduce a shared environmental effect if there is a significant correlation between 133 
the phenotype and age, because twins are always of the same age. Next, covariate 134 
analysis was performed, testing for: current smoking, body mass index (BMI), current 135 
oral contraceptive (OC) use and current hormone replacement therapy (HRT). It was 136 
our goal to test for a limited number of important covariates (i.e., age and BMI), 137 
rather than a more extensive list of potential covariates with more moderate effect 138 
sizes. This choice is unlikely to have biased our heritability estimates, because the 139 
potential effects of these covariates, in as far as they represent environmental 140 
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influences, will have ended up in the estimate of the Unique Environmental variance 141 
components E). No significant contribution to CRP variance was found for smoking, 142 
OC and HRT (p>0.05), the covariate models used were: 1) Age and 2) Age + BMI. 143 
That is, lnCRP was adjusted for age in model 1 and for both age and BMI in model 2 144 
after which the residuals were used in the model fitting. Models were fitted to the raw 145 
data using normal theory maximum likelihood allowing inclusion of incomplete data, 146 
for example, when data were only available in one twin of a pair or in a limited 147 
number of visits.  148 
Linear mixed model analysis was applied in longitudinal analyses to determine 149 
whether lnCRP differed between visits while accounting for both repeated 150 
measurements and twin relatedness by including the twin and family identification 151 
numbers as random effects in the model. Models with and without BMI as fixed effect 152 
were analyzed. The same approach was also used to test for differences in lnCRP 153 
levels between visits among those twins that returned for a second and/or a third 154 
visit. In simple cross-sectional analyses we used generalized estimating equations 155 
(GEE) to take account of the relatedness between twins. For example, to evaluate 156 
potential selective drop out over the different visits, we tested for the difference in 157 
age, BMI and lnCRP at baseline (i.e., visit 1) between twins that returned for a 158 
second or third visit and those that did not return using GEE. GEE was also used to 159 
test for differences in baseline characteristics between MZ and DZ twins. 160 
 161 
Model fitting  162 
Structural equation modeling (SEM) was the primary method of analysis. SEM is 163 
based on the comparison of the variance-covariance matrices in MZ and DZ twin 164 
pairs and allows separation of the observed phenotypic variance into its genetic and 165 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
8 
 
 
 
environmental components: additive (A) or dominant (D) genetic components and 166 
common (C) or unique (E) environmental components, the latter also containing 167 
measurement error. The choice to start with either D or C in the full model depends 168 
on the relation between the MZ (rMZ) and DZ (rDZ) twin correlations. A D component 169 
is implied if 2xrDZ<rMZ whereas a C component is indicated if 2xrDZ>rMZ. Dividing 170 
each of these components by the total variance yields the different standardized 171 
components of variance. For example, the narrow sense heritability (h2) can be 172 
defined as the proportion of the total variance attributable to additive genetic variation 173 
[19].  174 
For the longitudinal analysis, a trivariate SEM or path model (also known as a 175 
Cholesky decomposition, Figure 1) was used. With this model we can estimate both 176 
the heritability of CRP at different times of measurement separately, and also the 177 
genetic (rg) and environmental (re or rc) correlations between different time points, 178 
giving an estimation of the (in)stability of genetic and environmental influences with 179 
advancing age. We can further test whether the genes influencing CRP are the same 180 
(i.e. rg=1), partly the same (i.e. 0 < rg <1) or entirely different (i.e. rg=0) at different 181 
times of measurement (and therefore different ages). If they are partly the same, this 182 
bivariate model allows quantification of the amount of overlap between genes 183 
influencing CRP at different ages by calculating the genetic correlation between the 184 
traits: rg = COVA (trait 1, trait 2)/√(VAtrait1 * VAtrait2). 185 
Shared and unique environmental correlations can be calculated in a similar 186 
fashion [44,45]. In order to test for differences between twin 1 and twin 2, visits 1, 2 187 
and 3 and differences between MZ and DZ twins, we tested whether the means 188 
could be set equal between different twins (twin 1 and twin 2), time points (visit 1, 2 189 
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and 3) and zygosity groups (MZ and DZ) without a decline in model fit. A significant 190 
decline indicates that means cannot be assumed to be equal. 191 
 192 
--Insert-Figure-1- about here-- 193 
 194 
Software 195 
All data handling and preliminary analyses were done with STATA (version 10.1, 196 
Statacorp, TX, USA). Quantitative genetic modeling was carried out using the Mx 197 
software package [46].  198 
Models were fitted to the raw data using normal theory maximum likelihood 199 
allowing inclusion of incomplete data, for example, when data were only available in 200 
one twin of a pair or in a limited number of visits. Using this method, Mx yields 201 
efficient maximum likelihood estimates even in the case of missing data through 202 
calculating twice the negative log-likelihood of the data for each observation (i.e. twin 203 
pair) [46]. This procedure follows the theory described by Lange et al., [47] based on 204 
the multivariate normal probability density function of a vector of observed scores. 205 
 206 
Results 207 
In Figure 2 the distributions of lnCRP at the three visits for all twins combined are 208 
shown. lnCRP levels significantly increased from visit 1 (V1) to visit 2 (V2) (p=4.4x10-209 
25) and between V1 and visit 3 (V3) (p=1.2x10-15), but not between V2 and V3 210 
(p=0.69). Adjustment for BMI did not meaningfully change these results. The median 211 
(IQR) follow-up time was 5.60 (2.87-7.56) years between V1 and V2, 6.17 (4.10-7.53) 212 
between V2 and V3 and 9.58 (8.00-10.46) between V1 and V3. When limiting the 213 
analyses to individuals who returned for all 3 visits (robustness check), results were 214 
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very similar. lnCRP levels among the 2,251 “returners” significantly increased in the 215 
interval between V1 and V2 (p=1.8x10-29), and between V1 and V3 (N= 528; 216 
p=4.1x10-22), but not between V2 and V3 (N= 528; p=0.62) (Supplementary Figure 217 
1). Additionally adjusting lnCRP for BMI did not meaningfully change these results. 218 
 219 
--Insert-Figure-2-about here-- 220 
 221 
Baseline characteristics of MZ and DZ twins for the three visits are 222 
summarized in Table 1. Significant differences between MZ and DZ twins exist for 223 
age (Visit 2 and 3, p<0.01), BMI (Visit 2, p<0.05) and lnCRP levels (Visit 1 and 2, 224 
p<0.05). In our twin models we corrected lnCRP for both age and BMI.  225 
Even though we optimally made use of the available follow-up measures of 226 
CRP over a ten year period, only subsamples of twins returned for the second and/or 227 
third visit. Those twins that returned for a second and/or third visit were not entirely 228 
representative of the whole sample as they were several years older, had lower BMIs 229 
and lower levels of CRP at baseline (details given in Supplementary Table 2). 230 
Table 2 shows the intraclass twin correlations and results of the univariate 231 
SEM analysis of the two models for each of the three visits. For all three visits and 232 
both age adjusted, and age plus BMI adjusted lnCRP values MZ twin correlations 233 
were at least about twice as large as the DZ correlations clearly indicating the 234 
importance of genetic effects on lnCRP. In all models and visits, an AE-model was 235 
the best-fitting model. Heritabilities range from 0.46-0.52 (model 1) and 0.49-0.51 236 
(model 2). The heritabilities remain relatively stable over time and their confidence 237 
intervals overlap for all visits and models. 238 
 239 
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--Insert-Table-1-about here— 240 
 241 
Table 3 shows the results of the longitudinal trivariate analysis (Cholesky 242 
decomposition). We first tested effects of twin, visit and zygosity on the means. For 243 
model 1, mean values of twin 1 and twin 2 could be set equal within MZ and within 244 
DZ twins, but could not be set equal across visits and zygosity groups. For model 2, 245 
in which CRP was adjusted for BMI, the means could additionally be set equal across 246 
all 3 visits, but remained different between MZ and DZ twins (see also Table 1). 247 
Since CRP levels between MZ and DZ twin pairs were different we allowed the 248 
means to remain different among zygosity groups in our statistical model to ensure 249 
that these differences could not bias the variance component. 250 
No evidence for a significant effect of genetic dominance was found as the AE 251 
model fitted best for both models. Heritability estimates for CRP were around 50% 252 
and very stable over time (0.50-0.53). Adjustment for BMI reduced heritabilities 253 
somewhat (0.45–0.49).  254 
The genetic correlations between first and second (respectively second and 255 
third) follow-up visits were 0.82 and 0.85 (model 1), and 0.78 and 0.77 (model 2). 256 
These correlations are large, but significantly smaller than 1 based on the 257 
nonoverlapping 95% CIs indicating the emergence of new genetic effects with age. 258 
When comparing the first with the third visit, the genetic correlation dropped (0.66 for 259 
model 1 and 0.55 for model 2), indicating increasingly different genetic effects with 260 
age. Environmental correlations between first and second (respectively second and 261 
third) follow-up visits were much smaller than the genetic correlations with estimates 262 
of 0.16 and 0.27 (model 1), and 0.15 and 0.26 (model 2). When comparing the first 263 
with the third visit, the correlation remained the same (0.19).  264 
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As an additional sensitivity analysis we repeated the trivariate Cholesky 265 
modelling using only returning subjects, i.e., twins that participated in all three visits. 266 
Heritability estimates and genetic and environmental correlations showed similar 267 
results (Supplementary Table 1).  268 
 269 
Discussion 270 
The present study assessed the stability of genetic and environmental influences 271 
underlying baseline CRP levels, using a longitudinal classical twin design 272 
incorporating up to 3 follow-up measurements over a ten year period. We were able 273 
to demonstrate relative stable heritabilities with advancing age of around 50%, which 274 
are in the same range as previous studies [20–40]. High genetic correlations of 0.66 275 
to 0.85 between visits indicate that genes influencing CRP levels are mostly the 276 
same at different ages, whereas low environmental correlations of 0.16 to 0.27 show 277 
that environmental factors are largely different between visits. Genetic correlations 278 
were significantly different from 1, however, also indicating emergence of some new 279 
genetic effects on CRP with age. 280 
 281 
--Insert-Table-2-and-3-about here— 282 
 283 
The present study is, to our knowledge, the first to assess (and describe) the 284 
stability of genetic and environmental influences on baseline CRP levels in a 285 
longitudinal twin study. The longitudinal design with the long follow-up time of up to 286 
10 years, and the relatively large sample size provided more statistical power and 287 
methodological opportunities compared to previous smaller, cross-sectional studies. 288 
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We did not find evidence for genetic dominance however, in contrast to some 289 
previous cross-sectional twin studies that also had large sample sizes [37,39].  290 
A limitation of the present study however, is that our conclusions are not 291 
generalizable to men, or subjects with diseases since only data on relatively healthy 292 
women was assessed. The benefit of this homogenous sample on the other hand, is 293 
that the results cannot be confounded by gender or disease since these covariates 294 
have previously been shown to have significant effects [48].  295 
Even though we optimally made use of the available follow-up measures of 296 
CRP over a ten year period, only subsamples of twins returned for the second and/or 297 
third visits.However, the Mx software package is capable of handling missing data by 298 
obtaining maximum likelihood estimates and takes advantage of including all 299 
available data rather than complete cases only [46]. Furthermore, a sensitivity 300 
analysis including only twins for which CRP data was available for all three visits 301 
yielded similar findings. As such, we believe it is unlikely that the differences between 302 
returning and non-returning twins will have translated into major biases in our model 303 
fitting parameter estimates. 304 
An interesting feature of our study, as mentioned above, is that we are the first 305 
to demonstrate relative stable heritabilities over time in a longitudinal design, even 306 
though the CRP levels itself do not seem stable (higher CRP-levels are described 307 
with advancing age) [2–5]. The present results show that the increase in CRP levels 308 
off between V2 and V3 and partial differences in gene repertoire may well be 309 
responsible for this. However, the aim of the present study was to describe stability 310 
and change of (co)variance patterns over time in terms of changes in underlying 311 
genetic and environmental variance components rather than explaining trends 312 
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in,mean-CRP-levels over time. As such, further biological explanations of this age 313 
trend in mean CRP remain speculative. 314 
           It has been hypothesized before that increased CRP levels with age may 315 
result from increases in “low grade, systemic, chronic inflammation” (due to 316 
atherosclerosis for example) [2–5]. Based on our previous findings [10], one may 317 
have expected an increasingly important role for random (i.e., unique environmental) 318 
components reflecting reduced homeostatic control with age in this process. 319 
However, this was not supported by our recent findings.   320 
             The role of immunological pathways in somatic outcomes has well been 321 
established, as mentioned before in the introduction. This is, for example, illustrated 322 
by results on the role of microbial exposition in early life in the development of 323 
immune pathways and regulatory mechanisms [1], showing that a lack of exposition 324 
predisposes to “disrupted” immunological pathways and increased risk for allergic 325 
disorders. In this context, the relationship between Immunglobulin-E (IgE) and CRP 326 
would be of particular interest. This could be investigated in a multivariate twin study 327 
assessing the phenotypic and genetic relationship between IgE, CRP and age similar 328 
to our recent work on the relationship between neuroticism, CRP, fibrinogen, and IgG 329 
[49,50].  330 
 Genome-wide association studies (GWASs) have been able to identify several 331 
genomic loci associated  with serum levels of CRP. These studies have used large 332 
sample si es of adult population, but have not  compared (possibly different) genomic 333 
effects on CRP levels with advancing age [51,52].  ur results on the other hand 334 
 indicate emergence of some new genetic effects on CRP with age and hence, 335 
warrants the need to repeat  large GWAS studies with stratifying the study population 336 
for different age ranges. Post-G  S analyses  of the abovementioned CRP G  S 337 
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results revealed different biological processes involved in CRP  metabolism [53]. 338 
However, it is unclear whether these processes  are stable with advancing age. 339 
The present study provides evidence of a substantial role for genetics in the 340 
regulation of baseline CRP levels. Heritabilities are stable with advancing age, and 341 
(more interestingly) the impact of environmental components remains relatively 342 
stable too during the ten years our subjects were followed. Considering the genetic 343 
correlations were significantly smaller than 1 and reduced with follow-up time, genes 344 
regulating CRP levels at younger ages must be partly different from those at more 345 
advanced ages. These results are in contrast with previous (cross-sectional) findings 346 
of other inflammatory markers, which indicate moderation of (changing) unique 347 
environmental factors with age in the regulation of IL-1β and TNF-α levels [10].  348 
In conclusion, this study emphasizes the relatively stable role of genetics in 349 
regulation of CRP levels, emphasizing its potential as a biomarker of ageing over 350 
other, more biologically reactive substances, in the various immunological pathways. 351 
Furthermore, the present study highlights the importance of a combination of both 352 
environmental factors and complex genetic pathways underlying the ageing process. 353 
Finally, even though the quantitative role of genetics in regulation of baseline CRP 354 
levels remained largely the same with age, the actual genes responsible for these 355 
effects were partly different at different ages. As such, future gene finding efforts 356 
need to take this into account, for example through investigating gene by age 357 
interaction effects.  358 
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Figure captions  603 
 604 
Figure 1 605 
Path diagram for a bivariate model. For clarity, only one twin is depicted. A1, A2, A3 606 
= Genetic variance components; C1, C2, C3 = common environmental variance 607 
components; E1, E2, E3 = unique environmental variance components; V1, V2, V3 = 608 
Visit 1, 2 and 3; a11 through a33 = genetic path coefficients (or factor loadings); c11 609 
through c33 = common environmental path coefficients (or factor loadings); e11 610 
through e33 = unique environmental path coefficients (or factor loadings). 611 
 612 
Figure 2 613 
Distributions of lnCRP at the three visits. An asterix means that there is a significant 614 
difference (p<0.05) in ln(CRP) between the respective visits. 615 
 616 
Supplementary figure 1 617 
Distributions of paired differences in lnCRP between two visits. An asterix means that 618 
the paired difference is significantly different from zero (p<0.05).  619 
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Table 1: General characteristics of twins by zygosity and visit number. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Differences between MZ and DZ twins were tested using GEE with adjustment 
for age (for BMI) and age and BMI (for CRP). CRP was transformed by natural 
logarithm prior to analysis. Abbreviations: BMI, Body Mass Index; CRP, C-reactive 
protein; DZ, dizygotic twins; MZ, monozygotic twins; N, number of subjects; n.s., not 
significant. Data are given in mean±SD for age and BMI and median (IQR) for CRP.  
 
 MZ  DZ  p-value 
 N Age (years) N Age (years)  
      
Visit 1 2,955 49.1±13.4 3,246 48.3±12.4 ns 
Visit 2 934 57.9±10.1 1317 56.0±10.3 <0.01 
Visit 3 292 65.6±8.1 236 61.4±9.7  <0.01 
      
 N BMI (kg/m2) N BMI (kg/m2)  
Visit 1 2,955 25.4±4.6  3,246 25.6±4.7  ns 
Visit 2 934 25.7±4.2  1,317 26.3±4.8  <0.05 
Visit 3 292 26.1±4.2  236 26.3±4.4  ns 
      
 N CRP (mg/L) N CRP (mg/L)  
Visit 1 2,955 1.20 (0.48 – 3.15)  3,246 1.44 (0.58 – 3.47)  <0.05 
Visit 2 934 1.45 (0.68 – 3.39)  1,317 1.61 (0.72 – 3.89)  <0.05 
Visit 3 292 1.54 (0.73 – 3.18)  236 1.59 (0.73 – 3.80)  ns 
Table 1
  
 
Table 2: Intraclass correlations and parameter estimates of best fitting univariate models of lnCRP at the three visits  
Visit Model Intraclass correlations Univariate Model Fitting 
  rMZ (95% CI) rDZ (95% CI)  A (95% CI) E (95% CI) 
1 N, pairs 1457 1584    
 1 0.54 (0.50-0.58)  0.24 (0.20-0.29)  AE 0.52 (0.46 – 0.58) 0.48 (0.42 – 0.54) 
 2 0.48 (0.44-0.52) 0.20 (0.16-0.25) AE 0.51 (0.38 – 0.61) 0.49 (0.39 – 0.62) 
2 N, pairs 452 632    
 1 0.50 (0.43-0.57)  0.25 (0.18-0.33)  AE 0.51 (0.45 – 0.57) 0.49 (0.43 – 0.55) 
 2 0.46 (0.38-0.53) 0.24 (0.17-0.31) AE 0.51 (0.39 – 0.62) 0.49 (0.38 – 0.61) 
3 N, pairs 139 112    
 1 0.54 (0.43-0.66) 0.13 (0.00-0.31)  AE 0.46 (0.40 – 0.52) 0.54 (0.48 – 0.60) 
 2 0.51 (0.39-0.64) 0.15 (0.00-0.33) AE 0.49 (0.36 – 0.59) 0.51 (0.41 – 0.64) 
Note: Model 1, adjusted for age; Model 2, adjusted for age and BMI; A, additive genetic variance component; E, unique 
environmental variance component. 
 
 
Table 2
Table 3: Parameter estimates (95% CI) of best fitting trivariate models of lnCRP 
levels. 
 
 
 
 
 
 
 
 
Note: The best fitting model for all analyses was the AE model; Genetic correlations 
[rg (95% CI)] are given below the diagonal and environmental correlations [re (95% 
CI)] above the diagonal; Heritability [rg (95% CI)] estimates are given on the diagonal 
in bold, Model 1, adjusted for age; Model 2, adjusted for age and BMI. 
Model Visit 1 2 3 
1 1 0.53 (0.50-0.56) 0.16 (0.09-0.23) 0.19 (0.06–0.31) 
 2 0.82 (0.74-0.90) 0.50 (0.45-0.57) 0.27 (0.12-0.40) 
 3 0.66 (0.51-0.81) 0.85 (0.71-0.97) 0.52 (0.39-0.62) 
2 1 0.48 (0.44-0.51) 0.15 (0.08-0.22) 0.19 (0.06-0.31) 
 2 0.78 (0.70-0.87) 0.45 (0.40-0.52) 0.26 (0.12-0.39) 
 3 0.55 (0.40-0.70) 0.77 (0.61-0.92) 0.49 (0.36-0.59) 
Table 3
